Li G - Search Results

1

Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.

Rees RC, McArdle S, Mian S, Li G, Ahmad M, Parkinson R, Ali SA. Rees RC, et al. Among authors: li g. Curr Opin Mol Ther. 2002 Feb;4(1):49-53. Curr Opin Mol Ther. 2002. PMID: 11883695 Review.

2

Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.

Ali SA, Lynam J, McLean CS, Entwisle C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: li g. J Immunol. 2002 Apr 1;168(7):3512-9. doi: 10.4049/jimmunol.168.7.3512. J Immunol. 2002. PMID: 11907113

3

Phenotypic and functional differences of dendritic cells generated under different in vitro conditions.

McArdle SE, Ali SA, Li G, Mian S, Rees RC. McArdle SE, et al. Among authors: li g. Methods Mol Med. 2003;81:359-75. doi: 10.1385/1-59259-372-0:359. Methods Mol Med. 2003. PMID: 12725131 No abstract available.

4

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.

Parkinson RJ, Mian S, Bishop MC, Gray T, Li G, McArdle SE, Ali S, Rees RC. Parkinson RJ, et al. Among authors: li g. Prostate. 2003 Jun 15;56(1):65-73. doi: 10.1002/pros.10207. Prostate. 2003. PMID: 12746848

5

Anti-tumour therapeutic efficacy of OX40L in murine tumour model.

Ali SA, Ahmad M, Lynam J, McLean CS, Entwisle C, Loudon P, Choolun E, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: li g. Vaccine. 2004 Sep 9;22(27-28):3585-94. doi: 10.1016/j.vaccine.2004.03.041. Vaccine. 2004. PMID: 15315837 Free article.

6

Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF.

Ahmad M, Rees RC, McArdle SE, Li G, Mian S, Entwisle C, Loudon P, Ali SA. Ahmad M, et al. Among authors: li g. Int J Cancer. 2005 Jul 20;115(6):951-9. doi: 10.1002/ijc.20976. Int J Cancer. 2005. PMID: 15723299

7

Immunotherapeutic potential of DISC-HSV and OX40L in cancer.

Assudani DP, Ahmad M, Li G, Rees RC, Ali SA. Assudani DP, et al. Among authors: li g. Cancer Immunol Immunother. 2006 Jan;55(1):104-11. doi: 10.1007/s00262-005-0004-y. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 16001161 Free PMC article. Review.

8

International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.

Rees RC, Robins RA, Pawelec G, Muller L, Li G, Spendlove I. Rees RC, et al. Among authors: li g. Cancer Immunol Immunother. 2003 Jun;52(6):403-7. doi: 10.1007/s00262-002-0366-3. Epub 2003 Apr 9. Cancer Immunol Immunother. 2003. PMID: 12684847 Free PMC article. No abstract available.

9

Progress in vaccination against cancer (PIVAC) 2002.

Li G, Rees RC. Li G, et al. Expert Rev Vaccines. 2002 Oct;1(3):261-3. doi: 10.1586/14760584.1.3.261. Expert Rev Vaccines. 2002. PMID: 12901566 Free article. No abstract available.

10

Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53.

Rojas JM, McArdle SE, Horton RB, Bell M, Mian S, Li G, Ali SA, Rees RC. Rojas JM, et al. Among authors: li g. Cancer Immunol Immunother. 2005 Mar;54(3):243-53. doi: 10.1007/s00262-004-0596-7. Epub 2004 Sep 21. Cancer Immunol Immunother. 2005. PMID: 15449037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,862 results

Search Page

Filters